Best KPV Providers in 2026: Ranked and Reviewed
The tail end of alpha-melanocyte-stimulating hormone (α-MSH) is where the tripeptide KPV (lysine-proline-valine) comes from. Research interest centers on its blocking of NF-κB, which acts as the master switch for much of the inflammatory signaling in the body. It does that without the pigmentation or hormonal effects full-length α-MSH carries. Being a tripeptide, it crosses the same gut transporter that handles dietary di- and tripeptides, which is why it gets discussed as a possible oral option where most peptides are not. Note what the evidence is: preclinical work in animal models of contact dermatitis, bronchial inflammation and inflammatory bowel disease. Not human trials. Since October 28, 2026, an interim HHS policy says HHS does not intend to take enforcement action against state-licensed 503A pharmacies that compound it in topical and oral forms under strict conditions. The current status is below.
5 providers compared
New to KPV? Read our full KPV guide — evidence, dosing, safety and side effects.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
5 KPV providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.
- ★ Editor's Pick
single-ingredient KPV by prescription (oral)
From /moCheck pricingCoverageCheck intakeMedicationsBPC-157EpitalonGHK-CuKPVMOTS-cNAD+SemaxSermorelinTB-500 single-ingredient KPV by prescription (topical, oral)
From /moCheck pricingCoverage45 states + DCMedicationsBPC-157EpitalonGlutathioneKPVMOTS-cNAD+SemaxSermorelinTB-500single-ingredient KPV by prescription (oral)
From /moCheck pricingCoverageCheck intakeMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinKPVMOTS-cSermorelinTB-500Tesamorelin
Show 2 moreShow fewer
single-ingredient KPV by prescription (oral)
From /moCheck pricingCoverage27 states + DCMedicationsBPC-157CJC-1295 / IpamorelinEpitalonGHK-CuGlutathioneGonadorelinIpamorelinKPVMOTS-cNAD+PT-141SemaxSermorelinTB-500Tesamorelinsingle-ingredient KPV by prescription (topical, oral)
From /moCheck pricingCoverage1 stateMedications5-Amino-1MQBPC-157EpitalonGHK-CuKPVMOTS-cNAD+PT-141SemaxSermorelinTB-500Tesamorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick single-ingredient KPV by prescription (oral) | Check pricing | BPC-157EpitalonGHK-CuKPVMOTS-cNAD+SemaxSermorelinTB-500 | Check intake | Visit → | |
 single-ingredient KPV by prescription (topical, oral) | Check pricing | BPC-157EpitalonGlutathioneKPVMOTS-cNAD+SemaxSermorelinTB-500 | 45 states + DC | Visit → | |
 single-ingredient KPV by prescription (oral) | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuIpamorelinKPVMOTS-cSermorelinTB-500Tesamorelin | Check intake | Visit → | |
 single-ingredient KPV by prescription (oral) | Check pricing | BPC-157CJC-1295 / IpamorelinEpitalonGHK-CuGlutathioneGonadorelinIpamorelinKPVMOTS-cNAD+PT-141SemaxSermorelinTB-500Tesamorelin | 27 states + DC | Visit → | |
LL LiveNow Longevitysingle-ingredient KPV by prescription (topical, oral) | Check pricing | 5-Amino-1MQBPC-157EpitalonGHK-CuKPVMOTS-cNAD+PT-141SemaxSermorelinTB-500Tesamorelin | 1 state | Visit → |
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What this ranking checks
An interim HHS policy dated October 28, 2026 says HHS does not intend to take enforcement action against state-licensed pharmacies, federal facilities or licensed physicians that compound KPV under set conditions, until a final rule settles whether KPV goes on the 503A bulks list. The policy is interim enforcement discretion, and HHS’s Federal Register notice of October 30, 2026 calls it a draft that is not binding. It does not approve the peptide or add it to the 503A bulks list, it covers 503A pharmacies and physicians only (not 503B outsourcing facilities or research-use-only sellers), and HHS can narrow or withdraw it if safety or quality problems surface. The conditions: a patient-specific prescription; KPV acetate as the only active ingredient, with no blends; topical or oral use only, with no injectable form; an oral form needs documentation that it reaches adequate levels in humans; the raw powder must be made at an FDA-registered plant and tested, on its certificate of analysis, for identity, strength, purity, endotoxin, microbes, heavy metals and other impurities; adverse events and quality problems go to FDA MedWatch; and the label must say the product is compounded and not for resale.
What our ranking checks: that the seller's own website, read on November 5, 2026, offers KPV as a single ingredient, by prescription, in a route the policy covers. Sellers whose pages offer it only in a blend, or in a form outside those routes, are not ranked.
What no website read can show: which 503A pharmacy fills the prescription, the certificate of analysis and the source of the raw powder, whether the label says the product is compounded and not for resale, whether adverse events are reported to FDA MedWatch, and which device comes with it. Ask the seller for those before you pay. Being ranked here is not a finding that a seller meets the policy.
What each seller’s own page showed on November 5, 2026
- EnhancedRoute: oralPrice as listed: $119 for 1 month; 3-month plan $327 billed every 3 months ($109/mo)
- New TidesRoute: topical, oralPrice as listed: not published
- GoalBMI WellnessRoute: oralPrice as listed: not published
- RxPepsDirectRoute: oralPrice as listed: $2.25/cap (500mcg)
- LiveNow LongevityRoute: topical, oralPrice as listed: not published
Detailed Reviews
About the prices below: every dollar figure inside these provider summaries belongs to that clinic’s GLP‑1 weight-loss program. None is a KPV price. For KPV itself, read the price each seller’s own page listed, under “What this ranking checks” above. “Check pricing” in the tables means we hold no monthly figure for that seller that compares like for like, since many quote per vial, per capsule or per multi-month protocol.
Enhanced
Best for: single-ingredient KPV by prescription (oral)
Enhanced is the consumer health line of Enhanced Group, the publicly traded company behind the Enhanced Games sports competition. Independent clinicians prescribe compounded semaglutide and tirzepatide through it, plus microdose plans from $59 a month on a 12-month plan, testosterone and peptides including BPC-157, TB-500, MOTS-c, KPV, epitalon and semax. Semaglutide costs $129 a month, or $89 a month on a 12-month plan paid up front; tirzepatide costs $169, or $129 on the same terms.
Score Breakdown
Pros
- ✓Semaglutide costs $129 a month, 35% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $169 a month, 37% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price stays the same as your dose goes up
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
- ✓We found no FDA warning letters issued to Enhanced
Cons
- ✗Confirm it serves your state before you start the intake
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
New Tides
Best for: single-ingredient KPV by prescription (topical, oral)
New Tides is a physician-led telehealth practice that prescribes compounded semaglutide and tirzepatide and may also prescribe nine peptides, including the six named in the October 2026 HHS peptide policy. Nothing is charged at sign-up: the card you save is charged only when a physician sends a prescription, and there is no subscription. Semaglutide is $200 and tirzepatide $250 per prescription, the same at every dose, with the physician visit, medication and shipping included.
Score Breakdown
Pros
- ✓Semaglutide costs $200 a month, close to the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $250 a month, 7% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓The monthly price includes the medication, clinician visits and shipping
- ✓Serves 45 states and DC
- ✓We found no FDA warning letters issued to New Tides
Cons
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
GoalBMI Wellness
Best for: single-ingredient KPV by prescription (oral)
Score breakdown, pros and cons
GoalBMI Wellness is the telehealth arm of a Brooklyn bariatric surgery practice, with a bariatric surgeon, a physician assistant and a nurse practitioner prescribing for patients in New York, New Jersey, Pennsylvania and other states. Self-pay compounded semaglutide starts at $179 a month and tirzepatide at $279, or $749 for a 20-week tirzepatide program, after a $79 consultation. New York patients can also get peptide programs.
Score Breakdown
Pros
- ✓Semaglutide costs $133 a month, 33% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $195 a month, 28% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
- ✓We found no FDA warning letters issued to GoalBMI Wellness
Cons
- ✗Not included in the monthly price: clinician visits
- ✗Confirm it serves your state before you start the intake
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
RxPepsDirect
Best for: single-ingredient KPV by prescription (oral)
Score breakdown, pros and cons
Pricing is per vial: semaglutide/B12 from $25 a vial and tirzepatide/B12 from $45, after a $39 asynchronous online medical review, with no subscription required. A licensed 503A pharmacy in Texas compounds and dispenses. Prescriptions are written by licensed nurse practitioners and physician assistants, with Dr. Jonathan Snipes, MD as medical director. FedEx overnight shipping is a $15 flat pharmacy fee. Peptide RX LLC operates the brand in 28 states and DC.
Score Breakdown
Pros
- ✓Semaglutide costs $64 a month, 68% below the $199 median for compounded semaglutide across the sellers we compare
- ✓Tirzepatide costs $84 a month, 69% below the $269 median for compounded tirzepatide across the sellers we compare
- ✓The monthly price includes the medication and clinician visits
- ✓We found no FDA warning letters issued to RxPepsDirect
Cons
- ✗You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- ✗Not included in the monthly price: shipping, lab work, coaching
- ✗Serves only 27 states and DC, so check that yours is one of them
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
- ✗Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
LiveNow Longevity
Best for: single-ingredient KPV by prescription (topical, oral)
Score breakdown, pros and cons
LiveNow Longevity is a Las Vegas physician practice led by a board-certified neurologist that prescribes GLP-1 medications such as semaglutide and tirzepatide, plus peptides, for Nevada residents in clinic or by video. Care starts with an $88 evaluation that is credited toward your plan; medication is billed at the pharmacy's cost with no markup, and the management fee is quoted after the visit rather than published.
Score Breakdown
Pros
- ✓We found no FDA warning letters issued to LiveNow Longevity
- ✓Baseline bloodwork is required before a prescription
Cons
- ✗You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- ✗Serves one state only, so check that it is yours
- ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
How we rank, and what counts as “legit”
Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.
Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].
How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].
Frequently Asked Questions
Sources & methodology — as of November 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.